Priority Date: 07.11.08 (US 20080112686P)

Monoclonal antibodies to Fibroblast Growth Factor receptor 2

  • Application ID: EP14188785
  • Status: EXAMINATION IN PROGRESS

Attorneys

no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services
no operation time available
Headquarter in Cambridge and 2 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) Avidity IP Ltd is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 173 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.11.2008 - Priority Date (US 20080112686P)
  • 04.03.2015 - Publication A1 (EP2842573)

IPC Classification